Why India Needs to Establish an Infectious Disease Forecast Centre Right Away

Infectious Disease Forecasting models can help make decisions on relaxing the lockdown, while also estimating the requirements for equipment and masks.

India is in the middle of a 21-day nationwide lockdown to blunt the spread of COVID-19. Internal immigration and impracticality of social-distancing in joint families and crowded neighbourhoods make for a potentially volatile situation. Also rampant are anecdotes and preliminary evidence that India may have some sort of natural immunity to COVID-19 and the numbers of infections have not yet exploded as projected.

However, considering that the number of new infections is still growing, the big question is whether it is better to attribute the ‘low’ number of new infections and deaths to early social distancing and lockdown efforts or some hitherto unverified natural immunity. The decision about relaxing or continuing the lockdowns is not an easy one.

That is where the Infectious Disease Forecasting (IDF) models come in. Very briefly, these models divide the population into Susceptible, Infected and Removed (cured or dead) compartments and use mathematical equations with various biological and physical parameters to move people between these boxes. The outcomes are predictions and what-if scenarios of the future evolution of an infectious disease. These models are referred to as SIR (Susceptible-Infected-Removed) or SEIR (Susceptible-Exposed-Infected-Removed) models. They have been employed as a part of the decision-making process in recent outbreaks such as the SARS, H1N1 and Ebola.

What-if scenarios can include parameters such as the impact of lockdowns, environmental parameters (temperature, humidity), socioeconomic vulnerability and lack of social distancing in joint families.

Also Read: Tracking COVID-19 in India: The BCG Hypothesis

While the predictions of SRI/SEIR models are not always as accurate as one would want, they have proven very helpful for estimating the requirements for equipment, masks, and other non-pharmaceutical interventions (NPIs). In some sense, the prediction cannot be very accurate because constant interventions keep changing the evolution of the outbreak. Thus the models are shooting at a fast moving target. Nonetheless, it is clear as day that they are a valuable tool to deal with outbreaks.

The IDF and the related public health decision-making are broadly termed as outbreak science. Clearly, outbreak science should include data gathering, surveillance, and related genomic, viral, and pharmaceutical activities. Related efforts include awareness, training and capacity building to manage outbreaks.

India established a Department of Health Research (DHR) in 2007 under the Ministry of Health and Family Welfare to utilise modern health technologies in diagnosing, treating and vaccinating. Products are envisioned to find their way into the public health system. DHR has since been implementing its mandate of promoting and coordinating clinical and operation research.

It has set up international collaborations for training and scientific exchange. It administers the Indian Council of Medical Research (ICMR). DHR has set up a network of Viral Research and Diagnostics Labs, Multi-Disciplinary Research Units, and Model Rural Health Research Units. A Human Resource Development for Health Research is also implemented. There are data gathering, quality control and curating efforts as well as surveillance plans.

A 3D model of the novel coronavirus. Photo: Pixabay

The COVID-19 pandemic, which is still underway with no apparent end in sight, underscores the fact that IDF efforts in India are few and far in between. India needs a dedicated IDF centre like the ones established for weather and climate predictions. India’s weather and climate prediction enterprise is beginning to yield dividends on the investments made thus far. The applications of these predictions to various sectors like aviation and agriculture are also extending into other sectors.

A recent report by the Johns Hopkins University (JHU) can provide some guidelines for India on a charter for an IDF centre. The report notes the urgency of developing outbreak science and the need to effectively connect IDF with public health decisions. Current approach of calling on the academic and other communities to assist with IDF in the middle of an outbreak has severe limitations.

The mission mode approach taken to bring India to the world-standard on weather and climate forecasting must be urgently implemented for outbreak science as well. Many gaps identified by the JHU report are also relevant for India. The lack of formal mechanisms to allow quick access to data and funding resources is a glaring impediment. Outdated incentive systems in academia, which prevent quick transition to translational or operational research is also a handicap. There are other gaps such as sustained funding for advancing models to remain ready for new outbreaks.

Funding is also needed for extensive deployment of sustained networks for physical and social data gathering. It is a complex combination of pathogens, humans and environment that determine the reproduction rates and spread of infectious diseases. Resilience to contagion also depends on socioeconomic vulnerability and family structures (joint vs nuclear). All data, including medical histories must be brought under uniform protocols while also protecting privacy. Data visualisation is also critical for quickly crossing the language barriers between natural and social scientists, public health workers and decision makers.

While DHR has an effort for training and education, the IDF centre can add real-time outbreak experience when possible. For example, medical residents and students are now being pushed to the frontline in the battle against COVID-19. Capacity building to have trained IDF experts must consider the disparate climate regimes, demographic mixes and locally endemic diseases to cover a country as inhomogeneous as India.

Climate vulnerability of the neighbouring countries is a security threat to India. Similarly, health vulnerabilities of the neighbours are also a health security threat for India. Pathogens do not respect national boundaries and are easily transported by air in many cases. Some training provided by the IMD on weather and climate predictions to other countries can serve as an initial template for the IDF. Long-term funding and collaborations between infectious disease modellers and public health workers are needed not only within India but across the region.

As noted by the JHU report, during non-outbreak times, the teams should be working on developing, identifying, testing and evaluating new models and methodologies. Also important are best practices, effective non-pharmaceutical interventions and data visualisations. Improvement of data gathering efforts, novel crowdsourcing approaches at short notices, instrumentation and surveillance technologies are also important. These can be accomplished by sustained public-private-academic partnerships.

It is not a matter of ‘if’ another outbreak will occur that will bring humanity to its knees, but only a matter of ‘when’. With climate change and increased global connectivity and food demand, a dedicated IDF Centre is a national imperative for India. In fact, India should lead the effort to have a coordinated global network of IDFs to build on its related mandate under DHR. COVID-19 is a global disaster that should serve as an opportunity for IDF.

Raghu Murtugudde is a professor of atmospheric and oceanic science and Earth system science at the University of Maryland. He is currently a visiting professor at IIT Bombay.

Making the Right Decisions on India’s Health Spending

The government has decided to move to an ‘explicit’ process of priority setting for health expenditure, which looks at cost effectiveness and equity concerns.

The government has decided to move to an ‘explicit’ process of priority setting for health expenditure, which looks at cost effectiveness and equity concerns.

Representative image. Credit: Reuters/Anindito Mukherjee

Representative image. Credit: Reuters/Anindito Mukherjee

It is a fair assumption to make that everyone, everywhere wants to remain healthy. Sometimes, through no fault of our own, we get sick, and being sick costs us money. This may be an expense towards the cost of treatment or in the form of a missed opportunity to make money by being unable to work. Increasingly, governments across the world are working towards curtailing healthcare expenses borne by its citizens so that we don’t have to take money from our pockets to cover the costs of ill health. This is called providing universal health coverage and has been declared by the UN as a global goal which all countries must strive to achieve.

Dealing with a finite budget

One might put themselves in the position of the government in this scenario, for example a health secretary, who has a budget made available to him or her just for this – providing for health. This budget for health, however, has to stretch itself to meet the needs of the entire population, to cover everything from complex cancers and surgeries to training staff and building medical infrastructure. The district hospitals are demanding money be made available to them to pay for the equipment they require to perform surgeries, for doctors and nurses to staff the facilities, for repairs to make the hospital safe for staff and patients alike. The primary health centres (PHCs) are demanding additional funding – they too are understaffed and cannot afford to pay more skilled attendants or clinicians. In addition, they need an increase in their drug supplies for the growing numbers that come to the PHC each day. The community health centres (CHCs) are in the same position – they demand provision of nutrient-rich supplements for mothers and babies, who each day grow more malnourished as the CHC runs out of necessary supplies. But how can the secretary decide where this finite health budget is best spent? How does one weigh the myriad options to ensure that the money stretches as far as it possibly can?

What we know is this – every rupee can only be spent once. The health budget is finite, paying for one intervention inadvertently means that you are not paying for another. In economics, this is what we call the opportunity cost – taking the opportunity to pay for one area of health means a missed opportunity to pay for another. To treat one women for breast cancer may cost the same amount of rupees required to de-worm one lakh children. But how can the policy maker decide which is a better investment?

Policy makers in India and abroad are faced with these difficult decisions on a daily basis – to decide the best possible way in which the finite resources made available to health can be spent. This is no easy task. At present in India, many of these decisions are made on the basis of what we refer to as implicit rationing. This is the concept of “first in best dressed”, where those at the start of the queue may receive the treatment they need, while those at the back of the line may miss out by the time it is their turn.

Explicit priority setting, as opposed to implicit, refers to the process of making decisions according to clear and transparent criteria based on the best available evidence for effectiveness and cost of a given intervention, as well as taking into account equity considerations for the good of the entire population. This kind of priority setting is largely viewed as the most effective way in which to make decisions as to the best way a health budget is spent, weighing up all options and coming to a fair and just conclusion, towards the ultimate goal of universal health coverage – providing the services people need while protecting them from high out-of-pocket costs.

Moving towards health technology assessment

The positive news is that the government of India plans to move towards a more explicit priority-setting process for health. This form of rational priority setting is underpinned by a process called health technology assessment (HTA). HTA aims to introduce a more transparent, inclusive, fair and evidence-based process by which decisions regarding the allocation of health resources are made in India. ‘Health technology’ can refer to anything from a vaccine to a programme of improving breast-feeding practices to a complex surgical procedure – any intervention or programme related to health. HTA is an internationally recognised methodology, used by organisations such as the National Institute of Health and Care Excellence in the UK or the health intervention technology assessment programme (HITAP) in Thailand, which allows evidence for the effectiveness and cost of all similar interventions for a given health problem to be compared against each other, while taking into account any equity or equality considerations, to make the best possible decision as to which is the most cost effective intervention and whether it is worth the investment of government resources.

Ultimately, this is a very promising step forward towards the government’s agenda of providing universal health coverage to the people of India. This also provides a way to increase the involvement of the Indian public towards the way in which health resources are spent, by encouraging a consultative process underpinned by stakeholder involvement – a process that gives the people a voice and a platform from which to be heard. The Department of Health Research (DHR), Ministry of Health and Family Welfare, had been allocated this responsibility in the 12th five-year plan and have already taken active steps towards formalising this process. On July 25, 2016, a workshop was jointly convened by the government of India and the International Decision Support Initiative (IDSI), a global partnership network led by UK’s Imperial College and Thailand’s HITAP, to raise awareness of this initiative to formalise a system of HTA in India and bring together key stakeholders for consultation. The event was presided over by the ministers of state for health and family welfare, Faggan Singh Kulaste and Anupriya Patel, who expressed their support on behalf of the government of India to establish a system of HTA to inform health decision-making.

Since this important event, a number of significant steps forward have been taken by the government towards institutionalising HTA in India. A concept note for establishing a medical technology advisory board (MTAB) has been approved by the health minister. The DHR has compiled a list of multi-representative MTAB members, due to be approved by the health minister this week. A capacity gap analysis was drafted and sent to over 50 institutes across country to facilitate understanding of both current capacity to undertake health economic analysis in the country and gauge interest in contributing to the MTAB programme of work. From the results of this survey, memorandums of understanding are being signed between DHR and centres of excellence in health economics across country to collaborate in this area. In January 2017, a DHR-led group participated in a study tour to Thailand to understand how HTA has contributed to the country’s achievement of universal health coverage. Plans for undertaking a demonstration case HTA are underway, to be commenced by mid-2017, and DHR has taken active measures towards hiring an MTAB secretariat as a dedicated workforce to oversee the running of this work. Advertisement for positions in this team closed in late January 2017 and interviews are underway to ensure that staff will be in post shortly. Finally, plans for training for health economics capacity building, to be delivered by the IDSI, are underway and this is due take place in mid-2017.

The DHR is taking active measures to bridge the evidence to policy gap and ensure alignment of academic and policy interests through HTA towards the common goal of improving decision-making for health resource allocation to improve the health of the Indian population. The year 2017 will mark an exciting turning point for India towards a fairer, more inclusive, transparent and evidence-based system of setting priorities for the health of India. With more than one-sixth of the world’s population residing in India, this is an important step not only for the health of the Indian population, but for the global health community.

Laura Downey is technical advisor, global health and development, Imperial College London, UK and Soumya Swaminathan is secretary, Department of Health Research, Ministry of Health and Family Welfare, India.